IBMSC invested $15 million in domestic production of Shikimic Acid, which is needed to produce Tamiflu.  Prior to this investment, Shikimic Acid was sourced entirely from China. With this investment, we are promoting reliable access to critical flu treatments while creating jobs in the U.S.